The Personalized Medicine Biomarkers industry is rapidly evolving, driven by advancements in genomics and targeted therapies that are reshaping patient-specific treatment paradigms. Market Size and Overview The Global Personalized Medicine Biomarkers Market size is estimated to be valued at USD 28.61 billion in 2026 and is expected to reach USD 79.92 billion by 2033, exhibitin... https://cherry-dove-t1tktk.mystrikingly.com/blog/personalized-medicine-biomarkers-market-advances-driven-by-precision-healthcare